BACKGROUND: Despite the improvements in treatment over the last decades, periodontal disease (PD) affects millions of people around the world and the only treatment available is based on controlling microbial load. Diabetes is known to increase the risk of PD establishment and progression, and recently, glucose metabolism modulation by pharmaceutical or dietarian means has been emphasised as a significant modulator of non-communicable disease development. METHODS: The impact of pharmaceutically controlling glucose metabolism in non-diabetic animals and humans (REBEC, UTN code: U1111-1276-1942) was investigated by repurposing Metformin, as a mean to manage periodontal disease and its associated systemic risk factors. RESULTS: We found that glucose metabolism control via use of Metformin aimed at PD management resulted in significant prevention of bone loss during induced periodontal disease and age-related bone loss in vivo. Metformin also influenced the bacterial species present in the oral environment and impacted the metabolic epithelial and stromal responses to bacterial dysbiosis at a single cell level. Systemically, Metformin controlled blood glucose levels and age-related weight gain when used long-term. Translationally, our pilot randomized control trial indicated that systemic Metformin was safe to use in non-diabetic patients and affected the periodontal tissues. During the medication window, patients showed stable levels of systemic blood glucose, lower circulating hsCRP and lower insulin levels after periodontal treatment when compared to placebo. Finally, patients treated with Metformin had improved periodontal parameters when compared to placebo treated patients. CONCLUSION: This is the first study to demonstrate that systemic interventions using Metformin in non-diabetic individuals aimed at PD prevention have oral-systemic effects constituting a possible novel form of preventive medicine for oral-systemic disease management.

Centre for Craniofacial and Regenerative Biology FoDOCS King's College London London UK

Department of Periodontology and Implantology School of Dentistry São Leopoldo Mandic Campinas Brazil

Institute of Animal Physiology and Genetics Brno Czech Republic

NIHR BRC Genomics Research Platform Guy's and St Thomas' NHS Foundation Trust King's College London School of Medicine London UK

Periodontology Unit Centre for Host Microbiome Interactions FoDOCS King's College London London UK

Zobrazit více v PubMed

Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809–1820. doi: 10.1016/S0140-6736(05)67728-8. PubMed DOI

Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16(12):745–759. doi: 10.1038/s41579-018-0089-x. PubMed DOI PMC

Curtis MA, Diaz PI, Van Dyke TE. The role of the microbiota in periodontal disease. Periodontol 2000. 2020;83(1):14–25. doi: 10.1111/prd.12296. PubMed DOI

Axelsson P, Nyström B, Lindhe J. The long-term effect of a plaque control program on tooth mortality, caries and periodontal disease in adults. Results after 30 years of maintenance. J Clin Periodontol. 2004;31(9):749–757. doi: 10.1111/j.1600-051X.2004.00563. PubMed DOI

Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. II. Severely advanced periodontitis. J Clin Periodontol. 1984;11(1):63–76. doi: 10.1111/j.1600-051x.1984.tb01309.x. PubMed DOI

Peres MA, Macpherson LMD, Weyant RJ, Daly B, Venturelli R, Mathur MR, Listl S, Celeste RK, Guarnizo-Herreño CC, Kearns C, Benzian H, Allison P, Watt RG. Oral diseases: a global public health challenge. Lancet. 2019;394(10194):249–260. doi: 10.1016/S0140-6736(19)31146-8. PubMed DOI

Marchetti E, Monaco A, Procaccini L, Mummolo S, Gatto R, Tetè S, Baldini A, Tecco S, Marzo G. Periodontal disease: the influence of metabolic syndrome. Nutr Metab (Lond) 2012;9(1):88. doi: 10.1186/1743-7075-9-88. PubMed DOI PMC

Pirih FQ, Monajemzadeh S, Singh N, Sinacola RS, Shin JM, Chen T, Fenno JC, Kamarajan P, Rickard AH, Travan S, Paster BJ, Kapila Y. Association between metabolic syndrome and periodontitis: the role of lipids, inflammatory cytokines, altered host response, and the microbiome. Periodontol 2000. 2021;87(1):50–75. doi: 10.1111/prd.12379. PubMed DOI PMC

Burt BA. Periodontitis and aging: reviewing recent evidence. J Am Dent Assoc. 1994;125(3):273–279. doi: 10.14219/jada.archive.1994.0034. PubMed DOI

Wu Y, et al. Effect of aging on periodontal inflammation, microbial colonization, and disease susceptibility. J Dent Res. 2016;95(4):460–466. doi: 10.1177/0022034515625962. PubMed DOI PMC

Piers LS, Soares MJ, McCormack LM, O’Dea K. Is there evidence for an age-related reduction in metabolic rate? J Appl Physiol. 1998;85(6):2196–204. doi: 10.1152/jappl.1998.85.6.2196. PubMed DOI

Pontzer H, Yamada Y, Sagayama H, et al. Daily energy expenditure through the human life course. Science. 2021;373(6556):808–812. doi: 10.1126/science.abe5017. PubMed DOI PMC

van den Beld AW, Kaufman JM, Zillikens MC, Lamberts SWJ, Egan JM, van der Lely AJ. The physiology of endocrine systems with ageing. Lancet Diabetes Endocrinol. 2018;6(8):647–658. doi: 10.1016/S2213-8587(18)30026-3. PubMed DOI PMC

Kauppila TES, Kauppila JHK, Larsson NG. Mammalian mitochondria and aging: an update. Cell Metab. 2017;25(1):57–71. doi: 10.1016/j.cmet.2016.09.017. PubMed DOI

Clegg A, Hassan-Smith Z. Frailty and the endocrine system. Lancet Diabetes Endocrinol. 2018;6(9):743–752. doi: 10.1016/S2213-8587(18)30110-4. PubMed DOI

Karakelides H, Irving BA, Short KR, O'Brien P, Nair KS. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes. 2010;59(1):89–97. doi: 10.2337/db09-0591. PubMed DOI PMC

Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809–1820. doi: 10.1016/S0140-6736(05)67728-8. PubMed DOI

Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. CDC Periodontal disease surveillance workgroup: James beck (University of North Carolina, Chapel Hill, USA), Gordon Douglass (Past President, American Academy of Periodontology), Roy Page (University of Washin. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012;91(10):914–20. doi: 10.1177/0022034512457373. PubMed DOI

Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, Curiel TJ, de Cabo R, Franceschi C, Gems D, Ingram DK, Johnson TE, Kennedy BK, Kenyon C, Klein S, Kopchick JJ, Lepperdinger G, Madeo F, Mirisola MG, Mitchell JR, Passarino G, Rudolph KL, Sedivy JM, Shadel GS, Sinclair DA, Spindler SR, Suh Y, Vijg J, Vinciguerra M, Fontana L. Interventions to slow aging in humans: are we ready? Aging Cell. 2015;14(4):497–510. doi: 10.1111/acel.12338. PubMed DOI PMC

Chapple IL, Genco R. working group 2 of the joint EFP/AAP workshop. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP workshop on periodontitis and systemic diseases. J Periodontol. 2013;84(4 Suppl):S106–12. doi: 10.1902/jop.2013.1340011. PubMed DOI

D'Aiuto F, Gkranias N, Bhowruth D, Khan T, Orlandi M, Suvan J, Masi S, Tsakos G, Hurel S, Hingorani AD, Donos N, Deanfield JE, TASTE Group Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol. 2018;6(12):954–965. doi: 10.1016/S2213-8587(18)30038-X. PubMed DOI

O'Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553–65. doi: 10.1038/nri.2016.70. PubMed DOI PMC

Ly CH, Lynch GS, Ryall JG. A metabolic roadmap for somatic stem cell fate. Cell Metab. 2020;31(6):1052–1067. doi: 10.1016/j.cmet.2020.04.022. PubMed DOI

Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 2019;571(7764):183–192. doi: 10.1038/s41586-019-1365-2. PubMed DOI PMC

Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016;17(11):679–690. doi: 10.1038/nrm.2016.93. PubMed DOI PMC

Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20(6):953–966. doi: 10.1016/j.cmet.2014.09.018. PubMed DOI

Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M, Gomes AP, Ward TM, Minor RK, Blouin MJ, Schwab M, Pollak M, Zhang Y, Yu Y, Becker KG, Bohr VA, Ingram DK, Sinclair DA, Wolf NS, Spindler SR, Bernier M, de Cabo R. Metformin improves healthspan and lifespan in mice. Nat Commun. 2013;4:2192. doi: 10.1038/ncomms3192.PMID:23900241;PMCID:PMC3736576. PubMed DOI PMC

Sanchis A, García-Gimeno MA, Cañada-Martínez AJ, Sequedo MD, Millán JM, Sanz P, Vázquez-Manrique RP. Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease. Exp Mol Med. 2019;51(6):1–16. doi: 10.1038/s12276-019-0264-9. PubMed DOI PMC

Araújo AA, Pereira ASBF, Medeiros CACX, Brito GAC, Leitão RFC, Araújo LS, Guedes PMM, Hiyari S, Pirih FQ, Araújo Júnior RF. Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis. PLoS ONE. 2017;12(8):e0183506. doi: 10.1371/journal.pone.0183506. PubMed DOI PMC

Akram Z, Vohra F, Javed F. Locally delivered metformin as adjunct to scaling and root planing in the treatment of periodontal defects: a systematic review and meta-analysis. J Periodontal Res. 2018;53(6):941–949. doi: 10.1111/jre.12573. PubMed DOI

Baker PJ, Dixon M, Roopenian DC. Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect Immun. 2000;68(10):5864–5868. doi: 10.1128/IAI.68.10.5864-5868.2000. PubMed DOI PMC

Morley LA, Gomez TH, Goldman JL, Flores R, Robinson MA. Accuracy of 5 point-of-care glucometers in C57BL/6J Mice. J Am Assoc Lab Anim Sci. 2018;57(1):44–50. PubMed PMC

Joseph S, Aduse-Opoku J, Hashim A, Hanski E, Streich R, Knowles SCL, Pedersen AB, Wade WG, Curtis MA. A 16S rRNA gene and draft genome database for the murine oral bacterial community. Systems. 2021;6(1):e01222–20. PubMed PMC

Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–3. doi: 10.1038/nmeth.3869. PubMed DOI PMC

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8. PubMed DOI PMC

McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8(4):e61217. doi: 10.1371/journal.pone.0061217. PubMed DOI PMC

Mizraji G, Segev H, Wilensky A, Hovav AH. Isolation, processing and analysis of murine gingival cells. J Vis Exp. 2013;77:e50388. doi: 10.3791/50388. PubMed DOI PMC

Sanz M, Herrera D, Kebschull M, Chapple I, Jepsen S, Beglundh T, Sculean A, Tonetti MS. EFP workshop participants and methodological consultants treatment of stage I-III periodontitis—the EFP S3 level clinical practice guideline. J Clin Periodontol. 2020 doi: 10.1111/jcpe.13290. PubMed DOI PMC

Zaric S, Shelburne C, Darveau R, Quinn DJ, Weldon S, Taggart CC, Coulter WA. Impaired immune tolerance to Porphyromonas gingivalis lipopolysaccharide promotes neutrophil migration and decreased apoptosis. Infect Immun. 2010;78(10):4151–4156. doi: 10.1128/IAI.00600-10. PubMed DOI PMC

Fraser D, Caton J, Benoit DSW. Periodontal wound healing and regeneration: insights for engineering new therapeutic approaches. Front Dent Med. 2022 doi: 10.3389/fdmed.2022.815810. DOI

Caetano AJ, Yianni V, Volponi A, Booth V, D'Agostino EM, Sharpe P. Defining human mesenchymal and epithelial heterogeneity in response to oral inflammatory disease. Elife. 2021;10:e62810. doi: 10.7554/eLife.62810. PubMed DOI PMC

Jia Y, Qin Q, Fang CP, Shen W, Sun TT, Huang YL, Li WJ, Deng AM. UVB induces apoptosis via downregulation of CALML3-dependent JNK1/2 and ERK1/2 pathways in cataract. Int J Mol Med. 2018;41(5):3041–3050. doi: 10.3892/ijmm.2018.3478. PubMed DOI

Li H, Zuo J, Tang W. Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases. Front Pharmacol. 2018;17(9):1048. doi: 10.3389/fphar.2018.01048. PubMed DOI PMC

Tsuchida S, Bonkobara M, McMillan JR, Akiyama M, Yudate T, Aragane Y, Tezuka T, Shimizu H, Cruz PD, Jr, Ariizumi K. Characterization of Kdap, a protein secreted by keratinocytes. J Invest Dermatol. 2004;122(5):1225–1234. doi: 10.1111/j.0022-202X.2004.22511.x. PubMed DOI

Yang J, Chen Z, Liu N, Chen Y. Ribosomal protein L10 in mitochondria serves as a regulator for ROS level in pancreatic cancer cells. Redox Biol. 2018;19:158–165. doi: 10.1016/j.redox.2018.08.016. PubMed DOI PMC

Ishida M, Kawao N, Mizukami Y, Takafuji Y, Kaji H. Influence of Angptl1 on osteoclast formation and osteoblastic phenotype in mouse cells. BMC Musculoskelet Disord. 2021;22(1):398. doi: 10.1186/s12891-021-04278-6. PubMed DOI PMC

Everitt AR, Clare S, McDonald JU, Kane L, Harcourt K, Ahras M, Lall A, Hale C, Rodgers A, Young DB, Haque A, Billker O, Tregoning JS, Dougan G, Kellam P. Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. PLoS ONE. 2013;8(11):e80723. doi: 10.1371/journal.pone.0080723. PubMed DOI PMC

Koehne T, Markmann S, Schweizer M, Muschol N, Friedrich RE, Hagel C, Glatzel M, Kahl-Nieke B, Amling M, Schinke T, Braulke T. Mannose 6-phosphate-dependent targeting of lysosomal enzymes is required for normal craniofacial and dental development. Biochim Biophys Acta. 2016;1862(9):1570–1580. doi: 10.1016/j.bbadis.2016.05.018. PubMed DOI

Li M, Huang S, Zhang Y, Song Z, Fu H, Lin Z, Huang X. Regulation of the unfolded protein response transducer IRE1α by SERPINH1 aggravates periodontitis with diabetes mellitus via prolonged ER stress. Cell Signal. 2022;91:110241. doi: 10.1016/j.cellsig.2022.110241. PubMed DOI

Gonzalez OA, Kirakodu S, Nguyen LM, Orraca L, Novak MJ, Gonzalez-Martinez J, Ebersole JL. Comparative analysis of gene expression patterns for oral epithelial cell functions in periodontitis. Front Oral Health. 2022;3:863231. doi: 10.3389/froh.2022.863231. PubMed DOI PMC

Luo Y, Guo J, Xu P, Gui R. Long non-coding RNA GAS5 maintains insulin secretion by regulating multiple miRNAs in INS-1 832/13 cells. Front Mol Biosci. 2020;7:559267. doi: 10.3389/fmolb.2020.559267. PubMed DOI PMC

Bibert S, Aebischer D, Desgranges F, Roy S, Schaer D, Kharoubi-Hess S, Horisberger JD, Geering K. A link between FXYD3 (Mat-8)-mediated Na, K-ATPase regulation and differentiation of Caco-2 intestinal epithelial cells. Mol Biol Cell. 2009;20(4):1132–40. doi: 10.1091/mbc.e08-10-0999. PubMed DOI PMC

Li WQ, Zhong NZ, He J, Li YM, Hou LJ, Liu HM, Xia CY, Wang LZ, Lu YC. High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients. Oncol Rep. 2017;37(5):2865–2874. doi: 10.3892/or.2017.5528. PubMed DOI

Yan Y, Li T, Li Z, He M, Wang D, Xu Y, Yang X, Bai Y, Lao Y, Zhang Z, Wu W. Metformin suppresses the progress of diabetes-accelerated atherosclerosis by inhibition of vascular smooth muscle cell migration through AMPK-Pdlim5 pathway. Front Cardiovasc Med. 2021;8:690627. doi: 10.3389/fcvm.2021.690627. PubMed DOI PMC

Bentov I, Damodarasamy M, Plymate S, Reed MJ. Decreased proliferative capacity of aged dermal fibroblasts in a three dimensional matrix is associated with reduced IGF1R expression and activation. Biogerontology. 2014;15(4):329–37. doi: 10.1007/s10522-014-9501-8. PubMed DOI PMC

Lin WH, Chiu KC, Chang HM, Lee KC, Tai TY, Chuang LM. Molecular scanning of the human sorbin and SH3-doamain-containing-1 (SORBS1) gene: positive association of the T228A polymorphism with obesity and type 2 diabetes. Hum Mol Genet. 2001;10(17):1753–1760. doi: 10.1093/hmg/10.17.1753. PubMed DOI

Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21(7):426–440. doi: 10.1038/s41577-020-00488-6. PubMed DOI PMC

Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2014;64(1):57–80. doi: 10.1111/prd.12002. PubMed DOI PMC

Slots J. Human viruses in periodontitis. Periodontol 2000. 2010;53:89–110. doi: 10.1111/j.1600-0757.2009.00325.x. PubMed DOI

Morozumi T, Yashima A, Gomi K, Ujiie Y, Izumi Y, Akizuki T, Mizutani K, Takamatsu H, Minabe M, Miyauchi S, Yoshino T, Tanaka M, Tanaka Y, Hokari T, Yoshie H. Increased systemic levels of inflammatory mediators following one-stage full-mouth scaling and root planing. J Periodontal Res. 2018;53(4):536–544. doi: 10.1111/jre.12543. PubMed DOI

Van Dyke TE, Bartold PM, Reynolds EC. The nexus between periodontal inflammation and dysbiosis. Front Immunol. 2020;31(11):511. doi: 10.3389/fimmu.2020.00511. PubMed DOI PMC

Silver JG, Martin AW, McBride BC. Experimental transient bacteraemias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J Clin Periodontol. 1977;4(2):92–99. doi: 10.1111/j.1600-051x.1977.tb01888.x. PubMed DOI

Flynn MC, Kraakman MJ, Tikellis C, Lee MKS, Hanssen NMJ, Kammoun HL, Pickering RJ, Dragoljevic D, Al-Sharea A, Barrett TJ, Hortle F, Byrne FL, Olzomer E, McCarthy DA, Schalkwijk CG, Forbes JM, Hoehn K, Makowski L, Lancaster GI, El-Osta A, Fisher EA, Goldberg IJ, Cooper ME, Nagareddy PR, Thomas MC, Murphy AJ. Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis. Circ Res. 2020;127(7):877–892. doi: 10.1161/CIRCRESAHA.120.316653. PubMed DOI PMC

Teughels W, Feres M, Oud V, Martín C, Matesanz P, Herrera D. Adjunctive effect of systemic antimicrobials in periodontitis therapy: a systematic review and meta-analysis. J Clin Periodontol. 2020;47(Suppl 22):257–281. doi: 10.1111/jcpe.13264. PubMed DOI

Han X, Tao Y, Deng Y, Yu J, Sun Y, Jiang G. Metformin accelerates wound healing in type 2 diabetic db/db mice. Mol Med Rep. 2017;16(6):8691–8698. doi: 10.3892/mmr.2017.7707. PubMed DOI PMC

Campbell JM, Bellman SM, Stephenson MD, Lisy K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis. Ageing Res Rev. 2017;40:31–44. doi: 10.1016/j.arr.2017.08.003. PubMed DOI

Scott AJ, Ellison M, Sinclair DA. The economic value of targeting aging. Nat Aging. 2021;1:616–623. doi: 10.1038/s43587-021-00080-0. PubMed DOI PMC

Time to take gum disease seriously: the societal and economic impact of periodontitis. https://impact.economist.com/perspectives/healthcare/time-take-gum-disease-seriously-societal-and-economic-impact-periodontitis

Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505–522. doi: 10.1038/s41569-018-0064-2. PubMed DOI PMC

Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3(3):207–215. doi: 10.1016/S2213-8587(14)70134-2. PubMed DOI

Ebersole JL, Graves CL, Gonzalez OA, Dawson D, 3rd, Morford LA, Huja PE, Hartsfield JK, Jr, Huja SS, Pandruvada S, Wallet SM. Aging, inflammation, immunity and periodontal disease. Periodontol 2000. 2016;72(1):54–75. doi: 10.1111/prd.12135. PubMed DOI

Bajalan A, Bui T, Salvadori G, Marques D, Schumacher A, Rösing CK, Dahle UR, Petersen FC, Ricomini-Filho AP, Nicolau BF, Junges R. Awareness regarding antimicrobial resistance and confidence to prescribe antibiotics in dentistry: a cross-continental student survey. Antimicrob Resist Infect Control. 2022;11(1):158. doi: 10.1186/s13756-022-01192-x. PubMed DOI PMC

Periodontal ageing and its management via pharmacological glucose modulation